OSAM
COLL icon

O'Shaughnessy Asset Management’s Collegium Pharmaceutical COLL Stock Holding History

O'Shaughnessy Asset Management’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$957K Sell
26,428
-39,116
-60% -$1.34M ﹤0.01% 1280
2026
Q1 		$2.17M Buy
65,544
+5,238
+9% +$222K 0.01% 838
2025
Q4 		$2.79M Sell
60,306
-2,233
-4% -$93.4K 0.02% 709
2025
Q3 		$2.19M Sell
62,539
-11,226
-15% -$390K 0.01% 788
2025
Q2 		$2.18M Sell
73,765
-7,620
-9% -$217K 0.01% 736
2025
Q1 		$2.43M Buy
81,385
+675
+0.8% +$20.6K 0.02% 631
2024
Q4 		$2.31M Buy
80,710
+8,475
+12% +$280K 0.02% 613
2024
Q3 		$2.74M Buy
72,235
+8,635
+14% +$308K 0.02% 556
2024
Q2 		$2.05M Buy
63,600
+17,865
+39% +$619K 0.02% 597
2024
Q1 		$1.78M Buy
45,735
+28,100
+159% +$983K 0.02% 619
2023
Q4 		$543K Buy
17,635
+6,126
+53% +$153K 0.01% 973
2023
Q3 		$257K Buy
11,509
+1,440
+14% +$32.8K ﹤0.01% 1184
2023
Q2 		$216K Sell
10,069
-7,422
-42% -$169K ﹤0.01% 1176
2023
Q1 		$420K Buy
+17,491
New +$464K 0.01% 925
2021
Q4 		– Sell
-1,652
Closed -$33K – 1494
2021
Q3 		$33K Hold
1,652
– – ﹤0.01% 1792
2021
Q2 		$39K Hold
1,652
– – ﹤0.01% 1663
2021
Q1 		$39K Sell
1,652
-3,219
-66% -$76.5K ﹤0.01% 1474
2020
Q4 		$98K Sell
4,871
-3,706
-43% -$72.4K ﹤0.01% 1072
2020
Q3 		$179K Sell
8,577
-1,579
-16% -$28.5K 0.01% 735
2020
Q2 		$178K Sell
10,156
-1,209
-11% -$23.7K 0.01% 676
2020
Q1 		$186K Buy
+11,365
New +$235K 0.01% 488

Other funds holding COLL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

O'Shaughnessy Asset Management's COLL Position: Q2 2026 in Review

O'Shaughnessy Asset Management reduced its Collegium Pharmaceutical (COLL) stake by 60% in Q2 2026, selling an estimated $1.34M and leaving 26,428 shares worth $957K. The position accounts for ﹤0.01% of the portfolio, ranked #1280.

O'Shaughnessy Asset Management first reported a position in COLL in Q1 2020 and has held it in 21 quarters since. The position peaked at $2.79M in Q4 2025. 279 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

  • O'Shaughnessy Asset Management held 26,428 shares of Collegium Pharmaceutical worth $957K as of Q2 2026.
  • O'Shaughnessy Asset Management sold 39,116 Collegium Pharmaceutical shares in Q2 2026, an estimated $1.34M.
  • Collegium Pharmaceutical made up ﹤0.01% of O'Shaughnessy Asset Management's portfolio in Q2 2026, its #1280 holding.
  • O'Shaughnessy Asset Management first reported a position in Collegium Pharmaceutical in Q1 2020 and has held it in 21 quarters since.
  • O'Shaughnessy Asset Management's Collegium Pharmaceutical position peaked at $2.79M in Q4 2025.
  • 279 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on O'Shaughnessy Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.